Skip to main content

HCA Healthcare, Inc. stock price and financials

  • HCA · NYSE
  • Healthcare
  • Health Care Facilities
  • S&P 500
$499.05−0.32%Close 13 Nov 2026
Market value
$107.1B
P/E
15.81
EV / EBITDA
10.11
Dividend yield
0.6%
Beta · 1 year
0.28
Return · 1 year
+5.4%
52-week range$353.99 — $556.52

Share price close 16 Nov 2026

+8.2%1 monthHigh $510.70Low $449.96
$440$460$480$500$520Q3 FY2026 report filed 29 Oct 202623 Oct29 Oct4 Nov10 Nov16 Nov
+19.9%6 monthsHigh $510.70Low $361.32
$350$400$450$500$550Q2 FY2026 report filed 28 Jul 2026Q3 FY2026 report filed 29 Oct 20264 Jun2 Jul30 Jul26 Aug23 Sep20 Oct16 Nov
+8.6%year to dateHigh $545.13Low $361.32
$350$400$450$500$550Q4 FY2025 report filed 10 Feb 2026Q1 FY2026 report filed 29 Apr 2026Q2 FY2026 report filed 28 Jul 2026Q3 FY2026 report filed 29 Oct 202611 Feb30 Mar14 May1 Jul17 Aug1 Oct16 Nov
+7.3%1 yearHigh $545.13Low $361.32
$350$400$450$500$550Q4 FY2025 report filed 10 Feb 2026Q1 FY2026 report filed 29 Apr 2026Q2 FY2026 report filed 28 Jul 2026Q3 FY2026 report filed 29 Oct 2026Jan 26Mar 26Apr 26Jun 26Aug 26Sep 26Nov 26
+110%3 yearsHigh $545.13Low $240.42
$200$300$400$500$600Q4 FY2023 report filed 16 Feb 2024Q1 FY2024 report filed 2 May 2024Q2 FY2024 report filed 29 Jul 2024Q3 FY2024 report filed 31 Oct 2024Q4 FY2024 report filed 14 Feb 2025Q1 FY2025 report filed 1 May 2025Q2 FY2025 report filed 4 Aug 2025Q3 FY2025 report filed 30 Oct 2025Q4 FY2025 report filed 10 Feb 2026Q1 FY2026 report filed 29 Apr 2026Q2 FY2026 report filed 28 Jul 2026Q3 FY2026 report filed 29 Oct 2026Apr 24Sep 24Feb 25Aug 25Jan 26Jun 26Nov 26
+601%10 yearsHigh $545.13Low $70.31
$0$200$400$600Apr 18Sep 19Feb 21Jul 22Jan 24Jun 25Nov 26

Quarterly or annual report filed

In one paragraph

HCA Healthcare, Inc. reported revenue of $75.6 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 7.1% from fiscal 2024. Net income was $6.78 billion and diluted earnings per share $28.33.

In its latest reported quarter, the third quarter of fiscal 2026 (the three months to 30 Sep 2026), revenue was $19.8 billion, up 3.6% from a year earlier.

Figures from HCA Healthcare, Inc.'s annual and quarterly reports, compiled and checked by AapWire. Latest report filed 29 Oct 2026.

Against Health Care

Growth
Upper half
Revenue +8.0% a year over five years · 18th of 37
Profitability
Top quarter
Return on invested capital 19.4%, five-year average · 7th of 38
Balance sheet
Bottom quarter
Net debt 3.2× EBITDA · 30th of 38
Valuation
Cheaper than most
P/E 15.8 · 5th of 36

Among the sector's S&P 500 members with the figure; the longer the bar, the better placed. Debt and P/E rank lower first.

Revenue FY2025
$75.60B+7.1%
Net income
$6.78B+17.8%
Diluted EPS
$28.33+28.8%
Operating margin
15.9%+0.9 pts
Free cash flow
$7.69B+36.4%
Net debt
$47.66B+10.1%

Fiscal 2025 against fiscal 2024; bars show the last 10 fiscal years; net debt is borrowings and operating lease liabilities less cash and short-term investments at the year end.

Revenue and net income fiscal 2016–2025

  • Revenue
  • Net income
$0$20B$40B$60B$80BRevenue, FY16: $41.49BNet income, FY16: $2.89BFY16Revenue, FY17: $43.61BNet income, FY17: $2.22BFY17Revenue, FY18: $46.68BNet income, FY18: $3.79BFY18Revenue, FY19: $51.34BNet income, FY19: $3.5BFY19Revenue, FY20: $51.53BNet income, FY20: $3.75BFY20Revenue, FY21: $58.75BNet income, FY21: $6.96BFY21Revenue, FY22: $60.23BNet income, FY22: $5.64BFY22Revenue, FY23: $64.97BNet income, FY23: $5.24BFY23Revenue, FY24: $70.6BNet income, FY24: $5.76BFY24Revenue, FY25: $75.6BNet income, FY25: $6.78BFY25

Latest quarter · Q3 FY2026 to 30 Sep 2026, filed 29 Oct 2026 · Full results →

Revenue
$19.85B+3.6% on a year
Operating income
$2.96B−0.2% on a year
Net income
$1.58B−3.9% on a year
Diluted EPS
$7.27+4.5% on a year
Free cash flow
$3.10B−0.8% on a year

Comparable companies All of Health Care →

HCA Healthcare, Inc. beside the other S&P 500 members in Health Care Facilities, then the largest in Health Care, by market value.

HCA Healthcare, Inc. and comparable companies
CompanyMarket valueDay1 yearRevenue growthNet marginP/E
HCA HealthcareHCA$107.1B−0.3%+5.4%+5.8%8.6%15.8
Universal Health ServicesUHS—+0.1%−15.0%———
Eli LillyLLY$1.37T+1.1%+41.8%+45.5%31.9%49.6
Johnson & JohnsonJNJ$686.1B+0.8%+47.0%+7.8%16.2%42.6
AbbVieABBV$525.9B+0.2%+26.5%+10.7%15.7%51.1
AmgenAMGN$253.8B−0.3%+38.5%+8.2%24.1%27.0
Gilead SciencesGILD$210.2B+0.1%+36.2%+6.5%−12.5%—

Market value and moves at the latest close. Revenue growth compares the last twelve months with the twelve before; net margin and P/E over the last twelve months; P/E is left blank where earnings are negative.

Margins fiscal 2016–2025

  • Operating
  • Net
0%10%20%15.9%9.0%FY16FY19FY22FY25

HCA Healthcare, Inc. revenue by segment, product and region

Fiscal years, as the company cuts its revenue in its annual reports; the change on a year under each figure. A change is left out from a loss, from a sliver of revenue, or across a change in how the company reports.

By segment

HCA Healthcare, Inc. revenue by segment, by fiscal year
RevenueFY 2021FY 2022FY 2023FY 2024FY 2025
American Group$19.64B$20.86B+6.2%$22.32B+7.0%$24.67B+10.5%$26.45B+7.2%
Atlantic Group$19.10B$19.32B+1.2%$21.17B+9.5%$23.38B+10.5%$24.71B+5.7%
National Group$16.33B$16.77B+2.7%$18.11B+8.0%$19.66B+8.6%$21.28B+8.3%
Corporate and Other$3.69B$3.28B−11.0%$3.38B+2.9%$2.90B−14.2%$3.17B+9.3%
Total revenue$58.75B$60.23B$64.97B$70.60B$75.60B

Financial statements

Fiscal years, the latest ending 31 Dec 2025. Amounts in USD. On a narrow screen the table opens on the latest year and scrolls back.

Income statement

HCA Healthcare, Inc. income statement, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$41.49B$43.61B$46.68B$51.34B$51.53B$58.75B$60.23B$64.97B$70.60B$75.60B
Revenue growth+4.6%+5.1%+7.0%+10.0%+0.4%+14.0%+2.5%+7.9%+8.7%+7.1%
Operating income$6.52B$6.07B$7.07B$7.24B$7.25B$11.30B$10.35B$9.62B$10.56B$12.00B
Net income$2.89B$2.22B$3.79B$3.50B$3.75B$6.96B$5.64B$5.24B$5.76B$6.78B
Diluted EPS$7.30$5.95$10.66$10.07$10.93$21.16$19.15$18.97$22.00$28.33
Operating margin15.7%13.9%15.1%14.1%14.1%19.2%17.2%14.8%15.0%15.9%
Net margin7.0%5.1%8.1%6.8%7.3%11.8%9.4%8.1%8.2%9.0%

Cash flow

HCA Healthcare, Inc. cash flow, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Operating cash flow$5.65B$5.43B$6.76B$7.60B$9.23B$8.96B$8.52B$9.43B$10.51B$12.64B
Capital expenditure$2.76B$3.02B$3.57B$4.16B$2.83B$3.58B$4.39B$4.74B$4.88B$4.94B
Free cash flow$2.89B$2.41B$3.19B$3.44B$6.40B$5.38B$4.13B$4.69B$5.64B$7.69B

Balance sheet and shares

HCA Healthcare, Inc. balance sheet and shares, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$646.0M$732.0M$502.0M$621.0M$1.79B$1.45B$908.0M$935.0M$1.93B$1.04B
Total debt$31.38B$33.06B$32.82B$35.57B$33.06B$36.73B$40.20B$41.86B$45.24B$48.70B
Shareholders' equity−$7.30B−$6.81B−$4.95B−$2.81B$572.0M−$933.0M−$2.77B−$1.77B−$2.50B−$6.03B
Diluted shares396M372M355M348M344M329M295M276M262M239M
Dividends per share——$1.40$1.60$1.72$1.92$2.24$2.40$2.64$2.88

Quarterly figures

The last eight fiscal quarters, the latest ending 30 Sep 2026. Year-on-year growth compares the same quarter of the previous fiscal year.

HCA Healthcare, Inc. quarterly financial figures
PeriodQ4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$18.29B$18.32B$18.61B$19.16B$19.51B$19.11B$20.23B$19.85B
Revenue, year on year+5.7%+5.7%+6.4%+9.6%+6.7%+4.3%+8.7%+3.6%
Operating income$2.65B$2.86B$2.96B$2.96B$3.22B$2.86B$3.08B$2.96B
Net income$1.44B$1.61B$1.65B$1.64B$1.88B$1.62B$1.70B$1.58B
Diluted EPS$5.63$6.45$6.83$6.96$8.14$7.15$7.62$7.27
Free cash flow$1.27B$660.0M$3.03B$3.13B$870.0M$895.0M$1.10B$3.10B

Operating KPIs

The operating figures HCA Healthcare, Inc. reports beside its statements, then its revenue by product, segment and region, latest period first. Each links to its full history.

HCA Healthcare, Inc. operating KPIs
KPILatestPeriodChange on a yearRecent periods
Occupancy73.2%quarter to 30 Sep 2026up 1.5 points
Licensed beds (at quarter end)50,424at 30 Sep 2026down 0.3%
Admissions592,179quarter to 30 Sep 2026up 2.5%
Equivalent admissions1.1Mquarter to 30 Sep 2026up 2.8%
Inpatient revenue per admission$20,059quarter to 30 Sep 2026up 0.8%
Patient days2.7Mquarter to 30 Sep 2026up 1.6%
Financial condition and licensed hospital beds at (at quarter end)50,459at 30 Sep 2026down 0.2%
American Group revenue$6.8Bquarter to 30 Sep 2026up 2.4%
Atlantic Group revenue$6.4Bquarter to 30 Sep 2026up 4.5%
National Group revenue$5.7Bquarter to 30 Sep 2026up 3.9%

Method

Each period is read from the report the company filed and checked against accounting identities before it is shown; a figure that does not pass is left blank rather than estimated. Free cash flow is operating cash flow less capital expenditure. Fiscal years follow the company's own calendar. See data and methodology.

The same figures as plain text and JSON.

Questions

What was HCA Healthcare, Inc.'s revenue in fiscal 2025?

$75.6 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), as reported in its annual report.

What was HCA Healthcare, Inc.'s net income in fiscal 2025?

$6.78 billion for fiscal year 2025 (the twelve months to 31 Dec 2025).

What were HCA Healthcare, Inc.'s diluted earnings per share in fiscal 2025?

$28.33 for fiscal year 2025 (the twelve months to 31 Dec 2025).

What is HCA Healthcare, Inc.'s operating margin?

15.9% for fiscal year 2025 (the twelve months to 31 Dec 2025): operating income divided by revenue.

How much free cash flow did HCA Healthcare, Inc. generate in fiscal 2025?

$7.69 billion for fiscal year 2025 (the twelve months to 31 Dec 2025): operating cash flow less capital expenditure.

Where does HCA Healthcare, Inc.'s revenue come from?

In fiscal 2025, by segment: American Group $26.45B (35%), Atlantic Group $24.71B (33%), National Group $21.28B (28%), Corporate and Other $3.17B (4.2%), out of $75.60B in all, as stated in its annual report.

In the terminal

Twenty years of HCA Healthcare, Inc.'s figures, KPIs, guidance and a cash-flow valuation.

  • Every report line and operating figure, quarter by quarter
  • Guidance against what was delivered
  • Insider trades and institutional holders
  • Alerts on results, filings and price
See plans